liquid biopsy

A new liquid biopsy test uses next-generation sequencing to identify specific mutations in NSCLC

Higher conversion increases data quality and accuracy of results

ddPCR-based liquid biopsies can provide reliable and timely biomarker information to help guide treatment decisions

Reproducible workflows would help clinical labs successfully and routinely perform liquid biopsy assays

Exploring some of the microfluidic technologies used for cancer diagnosis

Penn study shows liquid biopsy may be viable option for both diagnosis and disease staging

Further research, conducted across a broader range of tumor types, will be necessary to confirm the study results

Potential of transplanted stem cell secretions as a liquid biopsy

A new approach reveals thousands of previously inaccessible RNA fragments in blood plasma that might serve as disease- and organ-specific biomarkers

A conversation with Maximilian Diehn, MD, PhD, associate professor of radiation oncology at  Stanford University